...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Just for fun...
Check out the MD&A dated September 9th, 2005 on Sedar. Something to do on a rainy Sunday. PVLee
Share
New Message
Please login to post a reply